Tobacco and Vaporisers Control (Specified Psychoactive Substances) (Authorisation) Regulations 2026

Tobacco and Vaporisers Control (Specified Psychoactive Substances) (Authorisation) Regulations 2026 Status:
Published in Subsidiary Legislation Supplement

on 24 Apr 2026

-

No. S 242
| Tobacco and Vaporisers Control Act 1993 |

| Tobacco and Vaporisers Control
(Specified Psychoactive Substances)
(Authorisation) Regulations 2026 |

| In exercise of the powers conferred by section 37 of the Tobacco and Vaporisers Control Act 1993, the Minister for Health makes the following Regulations: |

| Citation and commencement |

| 1. These Regulations are the Tobacco and Vaporisers Control (Specified Psychoactive Substances) (Authorisation) Regulations 2026 and come into operation on 1 May 2026. |

| Definitions |
2. In these Regulations —
| “collaborative practice agreement” and “collaborative prescribing practitioner” have the meanings given by regulation 2 of the Healthcare Services (Collaborative Prescribing Service) Regulations 2023 (G.N. No. S 398/2023); |

| “registered dentist” has the meaning given by section 2 of the Dental Registration Act 1999; |

| “registered medical practitioner” has the meaning given by section 2(1) of the Medical Registration Act 1997. |

| Authorised consumption of specified psychoactive substance |
3. Despite section 19E of the Act, a person (X) may consume a specified psychoactive substance if —
| (a) | the specified psychoactive substance is consumed for medical or dental purposes; |
| (b) | the specified psychoactive substance is not consumed using a Part 3A product; and |
| (c) | the specified psychoactive substance is consumed by X in either of the following circumstances:(i)the specified psychoactive substance is administered to X by —
| (A) | a registered medical practitioner; |
| (B) | a registered dentist; |
| (C) | a collaborative prescribing practitioner practising in accordance with the collaborative practice agreement applicable to him or her; or |
| (D) | any other person who is acting in accordance with the directions of any of the persons mentioned in sub‑paragraph (A), (B) or (C); |
(ii)the specified psychoactive substance is consumed by X in accordance with the directions of —
| (A) | a registered medical practitioner; |
| (B) | a registered dentist; or |
| (C) | a collaborative prescribing practitioner practising in accordance with the collaborative practice agreement applicable to him or her. | | (A) | a registered medical practitioner; | (B) | a registered dentist; | (C) | a collaborative prescribing practitioner practising in accordance with the collaborative practice agreement applicable to him or her; or | (D) | any other person who is acting in accordance with the directions of any of the persons mentioned in sub‑paragraph (A), (B) or (C); | (A) | a registered medical practitioner; | (B) | a registered dentist; or | (C) | a collaborative prescribing practitioner practising in accordance with the collaborative practice agreement applicable to him or her. |
| (A) | a registered medical practitioner; |
| (B) | a registered dentist; |
| (A) | a registered medical practitioner; |
| (B) | a registered dentist; or |
| (C) | a collaborative prescribing practitioner practising in accordance with the collaborative practice agreement applicable to him or her. |

| Made on 21 April 2026. |

| LAI WEI LIN |
Permanent Secretary
(Policy and Development),
Ministry of Health,
Singapore.
| [MH 78:29; AG/LEGIS/SL/309/2025/13] |

| (To be presented to Parliament under section 37(4) of the Tobacco and Vaporisers Control Act 1993). |